Phase 3
Completed N=29
Secondary Prevention of Osteoporosis
Source: ClinicalTrials.gov NCT00421343 ↗Enrolled (actual)
29
Serious AEs
3.5%
Results posted
Jun 2011
Primary outcomePrimary: Number Adherent With the Intervention — 29 participants
Summary
The purpose of this study is to develop and implement an evidence based protocol for the secondary prevention of osteoporotic fractures and falls, and to determine how compliance with this intervention improves muscle strength and functional status following a fracture.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number Adherent With the Intervention |
29 | — |
| SECONDARY Reasons for Non-willingness to Particiapte and Non-adherence With Intervention |
— | — |
Eligibility Criteria
Inclusion Criteria
- Admitted to rehab unit with the primary or secondary diagnosis of fracture
- English speaking
- Cognitively able to provide consent or health care proxy available and willing to provide consent
- Willing to cooperate
Exclusion Criteria
- Pathologic or periprosthetic fractures
- Creatinine clearance less than 15ml/minute
- Severe hypocalcemia
- Esophageal stricture or achalasia
- Taking other treatment for osteoporosis besides calcium or vitamin D in the past 6-months
- History of kidney stones in the past 6-months
Data sourced from ClinicalTrials.gov (NCT00421343). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.